Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Solid lipid nanoparticles as a drug delivery system for peptides and proteins
Publication

Publications

Solid lipid nanoparticles as a drug delivery system for peptides and proteins

Title
Solid lipid nanoparticles as a drug delivery system for peptides and proteins
Type
Another Publication in an International Scientific Journal
Year
2007
Authors
Almeida, AJ
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Souto, E
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Journal
Vol. 59
Pages: 478-490
ISSN: 0169-409X
Publisher: Elsevier
Other information
Authenticus ID: P-004-8VB
Abstract (EN): Solid lipid particulate systems such as solid lipid nanoparticles (SLN), lipid microparticles (LM) and lipospheres have been sought as alternative carriers for therapeutic peptides, proteins and antigens. The research work developed in the area confirms that under optimised conditions they can be produced to incorporate hydrophobic or hydrophilic proteins and seem to fulfil the requirements for an optimum particulate carrier system. Proteins and antigens intended for therapeutic purposes may be incorporated or adsorbed onto SLN, and further administered by parenteral routes or by alternative routes such as oral, nasal and pulmonary. Formulation in SLN confers improved protein stability, avoids proteolytic degradation, as well as sustained release of the incorporated molecules. Important peptides such as cyclosporine A, insulin, calcitonin and somatostatin have been incorporated into solid lipid particles and are currently under investigation. Several local or systemic therapeutic applications may be foreseen, such as immunisation with protein antigens, infectious disease treatment, chronic diseases and cancer therapy.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 13
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Topical delivery of oily actives using solid lipid particles (2007)
Another Publication in an International Scientific Journal
Souto, EB; Muller, RH; Almeida, AJ
Lipid nanoparticles (SLN (R), NLC (R)) for cutaneous drug delivery: Structure, protection and skin effects (2007)
Another Publication in an International Scientific Journal
Souto, EB; Almeida, AJ; Mueller, RH

Of the same journal

The formulation of nanomedicines for treating tuberculosis (2016)
Another Publication in an International Scientific Journal
Costa, A; Pinheiro, M; Magalhaes, J; Ribeiro, R; Seabra, V; Salette Reis; Sarmento, B
Reviving the interest in the versatile drug nystatin: A multitude of strategies to increase its potential as an effective and safe antifungal agent (2023)
Another Publication in an International Scientific Journal
Sousa, F; Nascimento, C; Ferreira, D; Reis, S; Paulo Costa
Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer (2008)
Another Publication in an International Scientific Journal
juzenas, p; chen, w; sun, yp; coelho, man; generalov, r; generalova, n; christensen, il
Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases (2013)
Another Publication in an International Scientific Journal
Fernando Andrade; Diana Rafael; Mafalda Videira; Domingos Ferreira; Alejandro Sosnik; Bruno Sarmento
Nanomaterials and molecular transporters to overcome the bacterial envelope barrier: Towards advanced delivery of antibiotics (2018)
Another Publication in an International Scientific Journal
RS Santos; Figueiredo C; Azevedo, NF; Braeckmans, K; De Smedt, SC

See all (6)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-09 at 03:52:19 | Privacy Policy | Personal Data Protection Policy | Whistleblowing